Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Not yet recruiting × Glioblastoma × Clear all

Phase

Phase 2 16 Phase NA 15 Phase 1 13 Phase 3 6 Phase 1/2 6 Phase EARLY_PHASE1 2 Phase 2/3 1

Status

Unknown 4 Recruiting 3 Active not recruiting 3 Withdrawn 2 Terminated 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 7 Stomach Neoplasms 6 Carcinoma, Hepatocellular 5 Neoplasm Metastasis 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Recurrence 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Leukemia, Myeloid, Acute 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Thymoma 1 Thymic epithelial tumor 1 Squamous NSCLC 1 Squamous Cell Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Prostate CA 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Parathyroid Neoplasms 1 Older Patients 1 Non-squamous Non-small Cell Lung Cancer 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07349693 2026-01-20

Cerebraca-02/3

Everfront Biotech Co., Ltd.

Phase 2/3 Not yet recruiting

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡